Overview
Lukasz Migas practices practicing medicine in Delft, Netherlands.
His clinical expertise encompasses Cerebral Amyloid Angiopathy, Primary Amyloidosis, and Niemann-Pick Disease.
He is actively involved in clinical research, co-authoring 30 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Lukasz G. Migas
Is Lukasz G. Migas a top-rated expert for Cerebral Amyloid Angiopathy?
MediFind is an objective health platform that identifies experts based on real-world data. Lukasz G. Migas is classified as an Experienced expert for Cerebral Amyloid Angiopathy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Lukasz G. Migas participate in research or clinical trials?
Yes. Lukasz G. Migas has published 30 articles and abstracts on conditions like Cerebral Amyloid Angiopathy. You can view a list of Lukasz G. Migas's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Cerebral Amyloid AngiopathyMr. Migas isExperienced. Learn about Cerebral Amyloid Angiopathy.
- Niemann-Pick DiseaseMr. Migas isExperienced. Learn about Niemann-Pick Disease.
- Primary AmyloidosisMr. Migas isExperienced. Learn about Primary Amyloidosis.